Dear , 

Welcome to Corporate Corner, International Health Partners' (IHP) first quarterly newsletter aimed at providing you, our valued partners, with regular insights, feedback, and updates on our work. We’ll keep you informed on all our programmes, upcoming shipments and how you can continue to support people in need around the world to access quality healthcare.
At IHP, we recognise that our corporate donors are the bedrock of our work. In 2020, as health budgets were squeezed around the world, we scaled up our operations to meet increasing need. As the year closed, we had quadrupled the number of treatments we sent in 2019, shipping 5.86 million treatments, all thanks to corporate partners like you.
Since January we have sent 60 Essential Health Packs to support partners in the Democratic Republic of Congo, Armenia and Central African Republic.  We have also sent shipments to meet the ever-growing needs in Sierra Leone, South Sudan, Kosovo, Yemen, Zimbabwe, Chad, Niger, Haiti and Lebanon; and have facilitated the first joint shipment to Jordan between two of our partners, Anera and International Medical Corps. Read on to see all we have coming up and how your organisation can get involved with our newest partner, World Child Cancer.
Upcoming shipments
2021 is proving to be a busy year at IHP, with 27 shipments of essential medicines and medical supplies currently in the works.
These include a shipment of maternal health medicines to our partner Life for African Mothers in Liberia, oncology medicine to Project Hope in Macedonia and  a number of shipments including essential medicines and medical supplies to Food for the Poor in Latin America.
Appeals: World Child Cancer
IHP has recently taken on a new Distributing Partner, World Child Cancer (WCC).
WCC is a UK registered charity and works to improve diagnosis, treatment, and support for children with cancer, and their families, in low- and middle-income countries. 
We are currently working on a first shipment of ambient primary healthcare products to Malawi, including Prednisolone and Omeprazole, which will support the ancillary care of paediatric cancer patients. Upon successful receipt of this first shipment, we will then send a shipment of cold chain paediatric oncology drugs.
If you are interested in supporting this partnership by donating any of the below products or would like a full proposal, please get in touch:
International Women's Day: challenging the health issues facing women
Women in low- and middle-income countries are more likely to face debilitating and life-threatening illnesses such as maternal mortality, female genital cutting, HIV/AIDs, and cervical cancer.
This month we celebrated International Women’s Day, which this year focused on the theme of #ChooseToChallenge. We want to challenge the health issues facing women around the world and prevent suffering due to limited access to adequate healthcare.
We support a number of programmes seeking to improve health outcomes for women in low- and middle-income countries. One of these is Life for African Mothers, an organisation tackling maternal mortality in sub-Saharan Africa. In Democratic Republic of Congo, the St Vincent medical centre in Bukavu recently received a donation of obstetric medicine through this partnership. It told us: “Since the introduction of [the donated obstetric medicine] in our hospital, the level of postpartum haemorrhage has dropped significantly. Both midwives and women who have given birth appreciate this therapy, and the news spreads by word of mouth among women waiting to give birth.” Angelique arrived at St Vincent needing help to give birth. She had a major haemorrhage following delivery, with the problem relating to uterine atony. Within 30 minutes of protocol being applied and medication given, “the problem was solved and this woman’s life [was] saved”.
Kimberlin Keller, Johnson & Johnson
We recently interviewed Kimberlin Keller, Senior Manager for Global Community Impact at Johnson & Johnson (J&J), to discuss how J&J is supporting women’s health and the importance of gender equity in global health. Kimberlin works closely with IHP to coordinate the generous donation of healthcare products and supplies. Read the full interview here
Industry news
Brexit & FMD
January 1 saw the UK leave the European Market. IHP is committed to ensuring a smooth Brexit transition for our EU corporate donors and we are working diligently to ensure our EU partners can continue to donate stock to us. The key changes to note moving forward are:
  • In relation to the EU Falsified Medicines Directive (Delegated Regulation 2011/62/EU) all stock manufactured for the EU market will need to be decommissioned prior to delivery to IHP
  • IHP is currently in the process of reviewing its Standard Operating Procedures and technical agreements in light of the Brexit changes
We will continue to update you with any future changes which may occur due to Brexit.
On February 24, we were delighted to see the news that the first COVAX vaccines arrived in Ghana’s capital, Accra. 600,000 doses of the COVID-19 vaccine were delivered through the vaccine-sharing initiative. The first round of allocation delivers doses of the AstraZeneca/Oxford vaccine and COVISHIELD. More information on this can be found here: COVAX publishes first round of allocations ( IHP stands for vaccine equity, and through our network of partners, we will continue to explore opportunities to contribute to the global vaccination process in low- and middle-income countries.
As we continue to respond to the needs of people with limited access to healthcare, we’re so grateful for your ongoing support. Without it, we would not be able to carry out this vital work.
Thank you 
Lydia Amartey-Williams - Corporate Partnerships Manager

Would you like to forward this email to a friend? Click here.